ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,472, issued on May 20, was assigned to OREXO AB (Uppsala, Sweden).
"Pharmaceutical device for use in intranasal administration" was invented by Jonas Savmarker (Uppsala, Sweden) and Robert Ronn (Uppsala, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a needle-free applicator that is suitable for administering a solid, amorphous, mono-particulate powder composition into a body cavity of a human patient, which cavity includes a mucosal surface, wherein the applicator comprises: (i) an opaque reservoir comprising said powder composition; (ii) an optional actuating means for generating a force upon actuation of the device by a user; ...